Online first
Original article
Published online: 2024-05-13

open access

Page views 50
Article views/downloads 36
Get Citation

Connect on Social Media

Connect on Social Media

Fungal peritonitis in peritoneal dialysis: a 5 years retrospective review in Northeast Thailand

Sirayut Waramit12

Abstract

Abstract Introduction : Peritoneal dialysis (PD) is a widely used renal replacement therapy for end-stage renal disease patients, offering various advantages. However, fungal peritonitis, a rare but life-threatening complication, remains less understood than bacterial peritonitis. Material and methods: This retrospective single-center study included all cases of fungal peritonitis in PD patients at Sakon Nakhon hospital, Northeast Thailand, from October 2017 to September 2022. Data on demographics, co-morbidities, prior antibiotic uses, laboratory values, microbiological features, treatments, and outcomes were collected. Results: The study involved 32 PD patients with fungal peritonitis. Patients were on average 59.0±11.29 years old, with a majority of females (68.8%). Diabetes (62.5%) was the leading cause of chronic kidney disease. Common co-morbidities included hypertension (75.0%) and diabetes (62.5%). Laboratory values showed variations, including elevated serum creatinine, urea levels, and low hemoglobin. Abdominal pain (81.3%) and clouding of dialysate (68.8%) were typical symptoms at presentation. Sepsis was present in 18.8% of patients. Candida species were the most common causative agents, with 100% receiving Amphotericin-B and 87.5% receiving Fluconazole for treatment. Most patients underwent catheter removal (93.8%). In terms of outcomes, 37.5% resumed PD, 43.8% transitioned to permanent hemodialysis, and the overall mortality rate was 15.6%. Conclusion: This study provides valuable insights into fungal peritonitis in PD patients, underlining the significance of regional considerations in clinical management. The findings underscore the need for standardized guidelines for diagnosis and treatment, accounting for local variations in causative agents and outcomes.

Article available in PDF format

View PDF Download PDF file

References

  1. García-Martos P, Gil de, Marín P, et al. Fungal peritonitis in continuous ambulatory peritoneal dialysis: a 10 cases description. Nefrología. 2009; 29(6): 534–539.
  2. Auricchio S, Giovenzana ME, Pozzi M, et al. Fungal peritonitis in peritoneal dialysis: a 34-year single centre evaluation. Clin Kidney J. 2018; 11(6): 874–880.
  3. Tasic S, Miladinovic-Tasic N, Djordjevic J, et al. Ten-year prevalence of fungal peritonitis in the city of Nis, South Serbia. Open Medicine. 2010; 5(1): 49–52.
  4. Huang JW, Hung KY, Wu KD, et al. Clinical features of and risk factors for fungal peritonitis in peritoneal dialysis patients. J Formos Med Assoc. 2000; 99(7): 544–548.
  5. Hu S, Tong R, Bo Y, et al. Fungal peritonitis in peritoneal dialysis: 5-year review from a North China center. Infection. 2019; 47(1): 35–43.
  6. Collins AJ, Foley RN, Herzog C, et al. Excerpts from the US Renal Data System 2009 Annual Data Report. Am J Kidney Dis. 2010; 55(1 Suppl 1): S1–420, A6.
  7. Nadeau-Fredette AC, Bargman JM. Characteristics and outcomes of fungal peritonitis in a modern North American cohort. Perit Dial Int. 2015; 35(1): 78–84.
  8. Li R, Zhang D, He J, et al. Characteristics analysis, clinical outcome and risk factors for fungal peritonitis in peritoneal dialysis patients: a 10-year case-control study. Front Med (Lausanne). 2021; 8: 774946.
  9. Szeto CC, Kwan BH, Chow KM. Peritonitis risk for older patients on peritoneal dialysis. Peritoneal Dialysis International: Journal of the International Society for Peritoneal Dialysis. 2008; 28(5): 457–460.
  10. Prasad N, Sinha A, Gupta A, et al. Fungal peritonitis in peritoneal dialysis patients. Perit Dial Int. 2005; 25(3): 207–222.
  11. Don BR, Kaysen G. Serum albumin: relationship to inflammation and nutrition. Semin Dial. 2004; 17(6): 432–437.
  12. Prasad KN, Prasad N, Gupta A, et al. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single centre Indian experience. J Infect. 2004; 48(1): 96–101.
  13. Ram R, Swarnalatha G, Neela P, et al. Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis: a single-centre experience in India. Nephron Clin Pract. 2008; 110(4): c207–c212.
  14. Agudoa RG, García-Martos P. Clinical and microbiological aspects of fungal peritonitis in peritoneal dialysis. Nefrología 2009. ; 29(6): 503–617.
  15. Auricchio S, Giovenzana ME, Pozzi M, et al. Fungal peritonitis in peritoneal dialysis: a 34-year single centre evaluation. Clin Kidney J. 2018; 11(6): 874–880.
  16. Juarez Villa D, Cano Escobar KB, Toledo Ramirez S, et al. Fungal peritonitis associated with peritoneal dialysis due to non-albicans candida: a case series. Cureus. 2022; 14(12): e32658.
  17. Baer RA, Killen JP, Cho Y, et al. Non-candidal fungal peritonitis in Far North Queensland: a case series. Perit Dial Int. 2013; 33(5): 559–564.
  18. Matuszkiewicz-Rowinska J. Update on fungal peritonitis and its treatment. Perit Dial Int. 2009; 29 Suppl 2: S161–S165.
  19. Chang TIk, Kim HW, Park JT, et al. Early catheter removal improves patient survival in peritoneal dialysis patients with fungal peritonitis: results of ninety-four episodes of fungal peritonitis at a single center. Perit Dial Int. 2011; 31(1): 60–66.
  20. Wang AY, Yu AW, Lam CW, et al. et al.. A prospective study of infections in chinese patients during and after peritoneal dialysis. Perit Dial Int. 2017; 37(5): 554–561.
  21. Cho Y, Badve SV, Hawley CM, et al. Seasonal variation in peritoneal dialysis-associated peritonitis: a multi-center registry study. Nephrol Dial Transplant. 2012; 27(5): 2028–2036.
  22. Montravers P, Mira JP, Gangneux JP, et al. AmarCand study group. A multicentre study of antifungal strategies and outcome of Candida spp. peritonitis in intensive-care units. Clin Microbiol Infect. 2011; 17(7): 1061–1067.
  23. Kanjanabuch T, Nopsopon T, Chatsuwan T, et al. Advisory Board of Peritoneal Dialysis, Nephrology Society of Thailand. Predictors and outcomes of peritoneal dialysis-related infections due to filamentous molds (mycopdics). PLoS One. 2022; 17(5): e0268823.
  24. Szeto CC, Li PKT. Peritoneal dialysis-associated peritonitis. Clin J Am Soc Nephrol. 2019; 14(7): 1100–1105.
  25. Kofteridis DP, Valachis A, Perakis K, et al. Peritoneal dialysis-associated peritonitis: clinical features and predictors of outcome. Int J Infect Dis. 2010; 14(6): e489–e493.
  26. Fontán MP, Rodríguez-Carmona A, García-Naveiro R, et al. Peritonitis-Related mortality in patients undergoing chronic peritoneal dialysis. Perit Dial Int. 2005; 25(3): 274–284.
  27. Piraino B, Bernardini J, Brown E, et al. ISPD position statement on reducing the risks of peritoneal dialysis-related infections. Perit Dial Int. 2011; 31(6): 614–630.
  28. Davenport A. Peritonitis remains the major clinical complication of peritoneal dialysis: the London, UK, peritonitis audit 2002-2003. Perit Dial Int. 2009; 29(3): 297–302.
  29. Miles R, Hawley CM, McDonald SP, et al. Predictors and outcomes of fungal peritonitis in peritoneal dialysis patients. Kidney Int. 2009; 76(6): 622–628.
  30. Wang AY, Yu AW, Li PK, et al. Factors predicting outcome of fungal peritonitis in peritoneal dialysis: analysis of a 9-year experience of fungal peritonitis in a single center. Am J Kidney Dis. 2000; 36(6): 1183–1192.